Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Moodys
Baxter
Dow
AstraZeneca

Last Updated: June 25, 2022

UNITHROID Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Unithroid, and when can generic versions of Unithroid launch?

Unithroid is a drug marketed by Stevens J and is included in one NDA.

The generic ingredient in UNITHROID is levothyroxine sodium. There are ten drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Unithroid

A generic version of UNITHROID was approved as levothyroxine sodium by MYLAN on June 5th, 2002.

  Try it Free

Drug patent expirations by year for UNITHROID
Drug Prices for UNITHROID

See drug prices for UNITHROID

Drug Sales Revenue Trends for UNITHROID

See drug sales revenues for UNITHROID

Recent Clinical Trials for UNITHROID

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Children's Hospital of PhiladelphiaN/A
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)N/A
Brigham and Women's HospitalN/A

See all UNITHROID clinical trials

Pharmacology for UNITHROID
Drug Class l-Thyroxine

US Patents and Regulatory Information for UNITHROID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Stevens J UNITHROID levothyroxine sodium TABLET;ORAL 021210-001 Aug 21, 2000 AB1,AB2,AB3 RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Stevens J UNITHROID levothyroxine sodium TABLET;ORAL 021210-007 Aug 21, 2000 AB1,AB2,AB3 RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Stevens J UNITHROID levothyroxine sodium TABLET;ORAL 021210-004 Aug 21, 2000 AB1,AB2,AB3 RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Stevens J UNITHROID levothyroxine sodium TABLET;ORAL 021210-011 Aug 21, 2000 AB1,AB2,AB3 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
McKinsey
Johnson and Johnson
Boehringer Ingelheim
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.